fda removes semaglutide from drug shortage list february 21 2025 FDA's GLP-1 decision kicks off 'unprecedented' tussle over Drug shortages in 2024 reach

We understand that optimal health extends beyond just physical fitness

The lack of safety pharmacokinetics is particularly concerningwe dont actually know how humans metabolize this peptide

doi: 10.1016/j.molcel.2011.04.029 248 CaviedesAMaturanaBCorvalnKEnglerAGordilloFVaras-GodoyMet al

A comprehensive understanding of the systemic effects of GLP-1 receptor agonists is crucial because these medications impact multiple organ systems beyond their primary role in glucose regulation

Speak with your healthcare provider if side effects become difficult to manage, do not improve, or begin affecting your ability to eat and drink adequately